Skip to main content
. 2012 May;56(5):2435–2442. doi: 10.1128/AAC.06369-11

Table 3.

Drug exposure at steady state in serum and kidneys and log reduction of median kidney burden of mice receiving echinocandinsc

Compound and dosages AUC (mg · h/liter)
Log reduction in kidneys
Serum Kidney Experiments 1 to 3a
Experiment 4b
S3 R83 RR24 S3 R83 RR24
Anidulafungin
    High dose (12 mg/kg) 556.5 812.0 0.794 0.805 −0.982 0.901 1.053 ND
    Medium dose (6 mg/kg) 278.1 406.0 0.924 0.831 −0.097 0.717 0.673 ND
    Low dose (3 mg/kg) 139.0 203.0 −0.515 0.147 −0.130 0.340 0.522 ND
Caspofungin
    High dose (6 mg/kg) 786.2 1091.0 2.728* 1.850* −1.139 3.942 2.655 ND
    Medium dose (3 mg/kg) 393.1 545.4 2.517* 1.445 −0.176 3.067 2.053 ND
    Low dose (1.5 mg/kg) 196.6 272.7 1.878 0.367 −1.181 1.845 1.372 ND
Micafungin
    High dose (12 mg/kg) 373.7 443.6 1.431* 1.558* 0.021 1.747 1.528 ND
    Medium dose (6 mg/kg) 186.9 221.8 0.618 1.170 −0.854 1.243 1.535 ND
    Low dose (3 mg/kg) 93.4 110.9 0.437 0.768 0.021 0.757 1.462 ND
a

Six animals per group.

b

Three animals per group. ND, not done.

c

The echinocandins studied were anidulafungin (3, 6, and 12 mg/kg), caspofungin (1.5, 3, and 6 mg/kg), and micafungin (3, 6, and 12 mg/kg). Negative values indicate higher CFU counts than in untreated control kidneys. S3 indicates C. glabrata wild-type-challenged mice, R83 indicates Fks2p-S663F mutant-challenged mice, and RR24 indicates Fks1p S629P mutant-challenged mice. Significant log reduction is indicated by an asterisk.